Team-Franci-G

Class 78, graduate in Industrial Biotechnology with PhD in Biochemistry and Specialization in Clinical Pathology.
He is associate professor in Microbiology and Clinical Microbiology at the DIPMED of the University of Salerno.
He directs a group of people consisting of about 10 units. The research fields are manifold and range from bacteriology, to virology passing through parasitology. The melting point of all the themes of interest is the search for molecular mechanisms to be used as potential targets for the screening of molecules capable of altering the physio-pathogenicity in the micro-organism-host interaction. His training in the field of epigenetics and proteomics allows Professor Franci to conduct projects:

i) on the interaction between peptides and microbial membrane;
ii) screening of small molecules with epigenetic activity such as new anti-microbial drugs;
iii) studies of epigenetic mechanisms in the interaction of the host microorganism, in particular in the infection and replication phases of some of the most common viruses worldwide;
iv) study of epigenetic variations in human cells following exposure from “vesicles of the outer membrane” by K. Pneumoniae;
v) identification of the genome-binding proteome in HPV models;
vi) study of extracellular macrovesicles in the mechanisms of viral infections;
vii) Study of the microbiota and its alterations in human pathologies.

The many years spent abroad at the most important international research centres have contributed to making Professor Franci one of the reference people in the National and International scene for the identification of small commercial and proprietary molecules with epigenetic characteristics capable of interfere with homeostasis and microbiological pathogenicity. He made translational medicine his reason for living. He has won many corporate competitions such as Vulcanicamente 2019, Start-Cup Campania (2X), Tech-Hub, Mind The Bridge, etc. With his colleagues he has raised private, national and international funds for over 2 million euros. He is author of 50
international publications.